by TractManager | Oct 13, 2022 | Emerging Technology Report
CureSight is a software-based prescription digital therapeutic for treatment of amblyopia that utilizes eye tracking technology to improve visual acuity and stereo acuity by training the visual system to use both eyes simultaneously.If you have a Hayes login, click...
by TractManager | Oct 12, 2022 | Emerging Technology Report
CardiAmp Cell Therapy is a cell harvesting, processing, and injection kit for transendocardial delivery of autologous bone marrow-derived cells to the heart for treatment of ischemic heart failure. If you have a Hayes login, click here to view the full report on the...
by TractManager | Oct 7, 2022 | Emerging Technology Report
Valoctocogene roxaparvovec (AAV5-hFVIII-SQ) is a single-administration hemophilia A gene therapy that combines a viral capsid (adeno-associated virus type 5 [AAV5]) with a factor VIII (FVIII) gene. The therapeutic viral vector delivers FVIII DNA to patient cells,...
by TractManager | Oct 3, 2022 | Emerging Technology Report
Relyvrio (formerly AMX0035) is an oral fixed-dose combination of sodium phenylbutyrate (PB) and taurursodiol (TURSO). PB is a prescription drug used to treat urea cycle disorders and TURSO (also known as tauroursodeoxycholic acid [TUDCA]) is a widely available...
Recent Comments